✦ LIBER ✦

Control of advanced and refractory acute myelogenous leukaemia with sirolimus-based non-myeloablative allogeneic stem cell transplantation

✍ Scribed by David F. Claxton; Christopher Ehmann; Witold Rybka

Book ID: 108673287
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 105 KB
Volume: 130
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2005.05600.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic factors for patients with acu

Prognostic factors for patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing myeloablative or non-myeloablative allogeneic blood stem cell transplantation

✍ Thorsten Graef; Matthias Vaupel; Roland Fenk; Leilani Ruf; Fabian Zohren; Ulrich 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 1 views

## Abstract In this uni‐centre retrospective study, we studied 120 adults with acute myeloid leukaemia (AML) (__n__ = 88) and myelodysplastic syndrome (MDS) (__n__ = 32) who received first allogeneic HSCT to determine prognostic factors which are correlated with the outcome after myeloablative (MA)

Salvage Therapy of Refractory Chronic Di

Salvage Therapy of Refractory Chronic Disseminated Candidiasis in a Patient with Acute Myeloid Leukaemia and Secondary Prophylaxis During Allogeneic Stem Cell Transplantation

✍ Jörg J. Vehreschild; Karsten Krüger; Oliver Kurzai; Claudia Wickenhauser; Karoli 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 671 KB

Comparative outcome of reduced intensity

Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT)

✍ Aoudjhane, M; Labopin, M; Gorin, N C; Shimoni, A; Ruutu, T; Kolb, H-J; Frassoni, 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 180 KB

Comparison between two fludarabine-based

Comparison between two fludarabine-based reduced-intensity conditioning regimens before allogeneic hematopoietic stem-cell transplantation: fludarabine/melphalan is associated with higher incidence of acute graft-versus-host disease and non-relapse mortality and lower incidence of relapse than fludarabine/busulfan

✍ Shimoni, A; Hardan, I; Shem-Tov, N; Rand, A; Herscovici, C; Yerushalmi, R; Nagle 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 162 KB